TGFB1 and glioblastoma: Overall, miR-27a-3p inhibition in GBM cells resulted in a significant increase in the expression of certain genes, particularly some negative regulators of the TGF-β signaling pathway, such as SMURF2, TGIF2, and GSK3B (Figure 4a,b; Supplementary Table S4).